Articles by author

Below are the articles found for author J.W.M. van der Meer.

29 Results have been found.


Pitfall of modern genetics: recurrent erysipelas masquerading as autoinflammatory disease
Issue: July 2017, Volume: 75, Number: 6

E.J.W. Spierings, J.W.M. van der Meer, A. Simon
Cutaneous hyperpigmentation induced by doxycycline: a case series
Issue: January 2015, Volume: 73, Number: 1

S.P. Keijmel, M.E.E. van Kasteren, W.A.M. Blokx, J.W.M. van der Meer, M. van Rossum, C.P. Bleeker-Rovers
The challenge of Lyme disease: tired of the Lyme wars
Issue: March 2011, Volume: 69, Number: 3

B.J. Kullberg, A. Berende, J.W.M. van der Meer
Anakinra for the inflammatory complications of chronic granulomatous disease
Issue: February 2011, Volume: 69, Number: 2

F.L. van de Veerdonk, M.G. Netea, C.A. Dinarello, J.W.M. van der Meer
Chronic yersiniosis due to defects in the TLR5 and NOD2 recognition pathways
Issue: October 2010, Volume: 68, Number: 10

M.G. Netea, F. van der Leij, J.P.H. Drenth, L.A.B. Joosten, R. te Morsche, P. Verweij, D. de Jong, B-J. Kullberg, J.W.M. van der Meer
Benign uterine uptake of FDG: a case report and review of literature
Issue: September 2010, Volume: 68, Number: 9

D. Vriens, L.F. de Geus-Oei, U.E. Flucke, A.J. van der Kogel, W.J.G. Oyen, M.E. Vierhout, J.W.M. van der Meer
Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra)
Issue: October 2009, Volume: 67, Number: 9

E.J. Bodar, A. Simon, M. de Visser, J.W.M. van der Meer
50 years Netherlands Journal of Medicine - 2002, reshaping the journal
Issue: October 2008, Volume: 66, Number: 9

J.W.M. van der Meer
Defective interferon-gamma production in patients with hairy cell leukaemia
Issue: September 2008, Volume: 66, Number: 8

M.G. Netea, O. Hoitink, B.J. Kullberg, J.W.M. van der Meer, R. Raymakers
Reversible hypogammaglobulinaemia
Issue: November 2007, Volume: 65, Number: 10

I.M.E. Desar, C.M.R. Weemaes, M. van Deuren, J.W.M. van der Meer
Independent medical research
Issue: April 2007, Volume: 65, Number: 4

J.W.M. van der Meer, A.M. de Gier, W.P.M. van Swaaij, M.B. Katan
Recurrent erysipelas despite antibiotic prophylaxis: an analysis from case studies
Issue: March 2007, Volume: 65, Number: 3

J.B. Koster, B.J. Kullberg, J.W.M. van der Meer
Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency: a report of two cases and a brief review of the literature
Issue: May 2006, Volume: 64, Number: 5

I.M.E. Desar, M. Keuters, J.M.M. Raemaekers, J.B.M.J. Jansen, J.H.J. van Krieken, J.W.M. van der Meer
NOD2 3020insC mutation and the pathogenesis of Crohnís disease: impaired IL-1β production points to a loss-of-function phenotype
Issue: September 2005, Volume: 63, Number: 8

M.G. Netea, G. Ferwerda, D.J. de Jong, S.E. Girardin, B.J. Kullberg, J.W.M. van der Meer
Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model
Issue: July-August 2005, Volume: 63, Number: 7

E.J. Bodar, J.C.H. van der Hilst, J.P.H. Drenth, J.W.M. van der Meer, A. Simon
Side effects of anticytokine strategies
Issue: March 2005, Volume: 63, Number: 3

J.W.M. van der Meer, C. Popa, M.G. Netea
Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes
Issue: February 2005, Volume: 63, Number: 2

D.F. Verhage, D.S.C. Telgt, J.T. Bousema, C.C. Hermsen, GJ.A. van Gemert, J.W.M. van der Meer, R.W. Sauerwein
Antibiotic control measures in Dutch secondary care hospitals
Issue: January 2005, Volume: 63, Number: 1

J.A. Schouten, M.E.J.L. Hulsche, S. Natsch, R.P.T.M. Grol, J.W.M. van der Meer
Why donít medical textbooks teach? The lack of logic in the differential diagnosis
Issue: November 2003, Volume: 61, Number: 11

P.M.J. Stuyt, , J.W.M. van der Meer
Candida-specific interferon-„ deficiency and Toll-like receptor polymorphisms in patients with chronic mucocutaneous candidiasis
Issue: November 2003, Volume: 61, Number: 11

C.A.A. van der Graaf, M.G. Netea, J.P.H. Drenth, R.H. te Morsche, J.W.M. van der Meer, B.J. Kullberg
F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis
Issue: October 2003, Volume: 61, Number: 10

C.P. Bleeker-Rovers, S.J.H. Bredie, J.W.M. van der Meer, F.H.M. Corstens, W.J.G. Oyen
Genetic basis of host susceptibility to infections - Preface
Issue: Supplement March 2004, Volume: 62, Number: 3

B.M. de Jongh, S. de Marie, J.W.M. van der Meer, C.M.J.E. Vandenbroucke-Grauls, H.A. Verbrugh
Primary haemochromatosis: a missed cause of chronic fatigue syndrome?
Issue: December 2002, Volume: 60, Number: 11

D.W. Swinkels, N. Aalbers, L.D. Elving, G. Bleijenberg, C.M.A. Swanink, J.W.M. van der Meer
Abstract!
Issue: December 2002, Volume: 60, Number: 11

J.W.M. van der Meer, A.F.H. Stalenhoef, P. Smits, Th. Thien
Diagnosing chronic fatigue syndrome: comparison of a protocol and computerised questionnaires
Issue: April 2003, Volume: 61, Number: 4

J.B. Prins, L.D. Elving, H. Koning, G. Bleijenberg, J.W.M. van der Meer
Why publish in the Netherlands Journal of Medicine?
Issue: April 2003, Volume: 61, Number: 4

Th. Thien, J.W.M. van der Meer, A.F.H. Stalenhoef, P. Smits
Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy
Issue: June 2003, Volume: 61, Number: 6

H.W. Eijkhout, P.J. van den Broek, J.W.M. van der Meer
Immunomodulation by antimicrobial drugs
Issue: July 2003, Volume: 61, Number: 7

J.W.M. van der Meer
The effect of granisetron, a 5-HT3 receptor antagonist, in the treatment of chronic fatigue syndrome patients Ė a pilot study
Issue: September 2003, Volume: 61, Number: 9

G.K.H. The, J. Prins, G. Bleijenberg, J.W.M. van der Meer